Skip to content

A program of International Vaccine Access Center by Johns Hopkins Bloomberg School of Public Health

Value of Immunization Compendium of Evidence

Home
Evidence Briefs
Knowledge Hub
Advocacy
Vaccine Resources
About VoICE

The clinical impact and cost-effectiveness of measles-mumps-rubella vaccination to prevent measles importations among international travelers from the United States

Post navigation

← Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: A scoping review of published literature. 2006-2016

The exacerbation of Ebola outbreaks by conflict in the Democratic Republic of the Congo →

VoICE is a project of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Learn More About IVAC
Contact Us

© 2024 The International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health. All rights reserved

Translation Disclaimer